US 10,293,025 B2Granted

Oral administration compositions comprising an OB-fold protein variant

AssigneeAffilogic

InventorOlivier Kitten

Life of this patent

Estimating the term…

Abstract

The invention relates to an oral administration composition containing an OB-fold protein variant, and to the method for preparing the same.

Claims21

Dependent claims

An oral administration composition comprising a variant of a wild-type OB-fold protein, said variant having between 5 and 32 mutated residues in the interface of binding of said wild-type OB-fold protein to its natural ligand.

Dependencies are inferred from the claim text.

Facts

Application: 15/521,398Filed 23 Oct 2015
Priority: FR 14 6022624 Oct 2014
Published: US 2018/0085427 A129 Mar 2018
Granted: 21 May 2019
Term ends: Not estimatedThe source records don’t support an estimate.

Classification13 codes

A61K 38/164
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: from bacteria
A61K 9/0053
Galenical forms characterised by the site of application: mouth and digestive tract, i.e. intraoral and peroral administration
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61P 1/00
Drugs for disorders of the alimentary tract or the digestive system

Family

US 2018/0085427 A1Pre-grant publication · published 29 Mar 2018
US 10,293,025 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results